Jump Financial, LLC Amgen Inc Transaction History

Jump Financial, LLC

$3.53 Billion
Q1 2024

A detailed history of Jump Financial, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jump Financial, LLC holds 19,357 shares of AMGN stock, worth $6.02 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

19,357

Previous 15,182 27.5%

Holding current value

$6.02 Million

Previous $4.37 Million 25.87%

% of portfolio

0.16%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $1.12 Million - $1.36 Million	4,175 Added 27.5%	19,357 $5.5 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $2.02 Million - $2.27 Million	7,882 Added 107.97%	15,182 $4.37 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $1.86 Million - $2.31 Million	-8,496 Reduced 53.79%	7,300 $1.96 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $3.38 Million - $4 Million	15,796 New	15,796 $3.51 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $516,706 - $582,751	2,302 Added 111.75%	4,362 $983,000

Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $680,363 - $757,126	-2,949 Reduced 58.87%	2,060 $501,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $509,802 - $563,975	-2,325 Reduced 31.7%	5,009 $1.21 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1.46 Million - $1.67 Million	7,334 New	7,334 $1.65 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.58 Million - $1.85 Million	-7,452 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $1.51 Million - $1.68 Million	-6,481 Reduced 46.52%	7,452 $1.82 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $3.09 Million - $3.6 Million	13,933 New	13,933 $3.47 Million

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account

Jump Financial, LLC Amgen Inc Transaction History